Resources for Researchers

NIAID offers many resources to support your research, including reagents, model organisms, and tissue samples, to name just a few. Use the filters under Filter Search Results to narrow your search, or simply enter specific search terms in the search field.

Showing results filtered by:
ClEAR ALL
DAIT (Division of Allergy, Immunology, and Transplantation)
Datasets
7 Results

ImmPort

ImmPort is a Web portal that contains data from NIAID-funded immunology studies, including basic research and clinical trials. The portal provides online tools that allow users to analyze the data and visualize the results.

Immune Epitope Database and Analysis Resource (IEDB)

This free resource offers easy searching of experimental data characterizing antibody and T cell epitopes studied in humans, non-human primates, and other animal species.

ImmuneSpace

The ImmuneSpace database is currently composed of 21 studies covering 10 types of assays and 2,500 total participants.

Primary Immunodeficiency (PI) Diseases Registry at USIDNET

The Primary Immunodeficiency (PI) Diseases Registry collects validated data on all PI diagnoses from patients who give Informed Consent. The de-identified data in the registry is freely disseminated to those with research questions about PI diseases.

QuSAGE: Quantitative Set Analysis for Gene Expression

This Gene Set Enrichment-type test designed for analysis of microarray and RNASeq data is designed to provide a faster, more accurate, and easier to understand test for gene expression studies. QuSAGE extends previous methods with a complete probability density function (PDF).

Systems Immunology Toolkit

The tools in the Systems Immunology Toolkit will collectively allow you to upload microarray data, view that data on a gene-by-gene basis, overlay clinical data, analyze your data using a modular framework, compare your data to other datasets and diseases, and get a quick functional interpretatio

TrialShare

TrialShare is a transformative approach to data-sharing that enables clinical trial transparency.